IM Cannabis Corp. (IMCC)
3.20
-0.21
(-6.16%)
USD |
NASDAQ |
Aug 31, 15:07
IM Cannabis EPS Diluted (Quarterly) : -0.3399 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3399 |
| March 31, 2026 | -0.28 |
| December 31, 2025 | -0.9288 |
| September 30, 2025 | -0.5451 |
| June 30, 2025 | -0.0684 |
| March 31, 2025 | 0.0621 |
| December 31, 2024 | -0.2343 |
| September 30, 2024 | -0.3029 |
| June 30, 2024 | -0.9919 |
| March 31, 2024 | -1.868 |
| December 31, 2023 | -1.082 |
| September 30, 2023 | -0.7184 |
| June 30, 2023 | -1.172 |
| March 31, 2023 | -0.2354 |
| December 31, 2022 | -19.28 |
| September 30, 2022 | -83.08 |
| June 30, 2022 | -12.79 |
| March 31, 2022 | -8.053 |
| December 31, 2021 | -9.010 |
| September 30, 2021 | -3.063 |
| June 30, 2021 | -11.00 |
| March 31, 2021 | -2.738 |
| December 31, 2020 | -22.41 |
| September 30, 2020 | 0.659 |
| June 30, 2020 | -10.74 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5103 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | -0.292 |
| January 31, 2019 | -0.3481 |
| October 31, 2018 | -0.5066 |
| July 31, 2018 | -1.781 |
| April 30, 2018 | -1.424 |
| January 31, 2018 | -0.3755 |
| October 31, 2017 | -0.1919 |
| July 31, 2017 | -0.0272 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 2.565 |
| January 31, 2015 | -2.061 |
| October 31, 2014 | -2.172 |
| July 31, 2014 | -0.5035 |
| April 30, 2014 | -2.172 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| Teva Pharmaceutical Industries Ltd. | -0.5029 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -0.5737 |
| Purple Biotech Ltd. | 0.4069 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.168M |
| Revenue (Quarterly) | 5.482M |
| Total Expenses (Quarterly) | 8.632M |
| Enterprise Value | 64.05M |
| Gross Profit Margin (Quarterly) | 19.83% |
| Profit Margin (Quarterly) | -57.78% |
| Earnings Yield | -65.43% |
| Normalized Earnings Yield | -65.43 |